Rubén Andújar Espinosa

Castilla-Martinez M, Andujar-Espinosa R, Flores-Martin I, Reyes Cotes MH, Cabrejos-Perotti S, Miralles-Lopez JC, Carbonell-Martinez A, Bravo-Gutierrez FJ, Valverde-Molina J, Perez-Fernandez V; RE-ASGRAMUR GROUP. Early Effectiveness of Dupilumab in Patients With Type 2 Severe Asthma: A Prospective Real-Life Study. J Investig Allergol Clin Immunol. 2023 Apr 18;33(2):126-128. doi: 10.18176/jiaci.0872. Epub 2022 Nov 24. No abstract available. PubMed PMID: 36420744.

AÑO: 2023; IF: 7.2

36420744

Miralles Lopez JC, Andujar-Espinosa R, Bravo-Gutierrez FJ, Castilla-Martinez M, Flores-Martin I, Alemany-Frances ML, Pajaron-Fernandez MJ, Mora Gonzalez A, Valverde-Molina J, Perez-Fernandez V; RE-ASGRAMUR GROUP. Effectiveness of Benralizumab in Severe Eosinophilic Asthma Under Conditions of Routine Clinical Practice. J Investig Allergol Clin Immunol. 2022 Jun 20;32(3):220-223. doi: 10.18176/jiaci.0793. Epub 2022 Feb 15. No abstract available. PubMed PMID: 35166673.

AÑO: 2022; IF: 7.2

35166673

Hu-Yang C, Perez-Fernandez V, Andreu Rodriguez AL, Andujar Espinosa R, Valverde-Molina J. FEV1/FVC Cut-off Values for the Diagnosis of Airflow Obstruction in Pediatric Patients: The Pediatric Airflow Obstruction (PAO) Study. Arch Bronconeumol. 2022 May;58(5):442-443. doi: 10.1016/j.arbres.2021.03.021. Epub 2021 Apr 28. No abstract available. English, Spanish. PubMed PMID: 35312563.

AÑO: 2022; IF: 8.0

35312563

Bravo-Gutierrez FJ, Miralles-Lopez JC, Valverde-Molina J, Alemany Frances ML, Andujar-Espinosa R, Castilla-Martinez M, Aviles-Ingles MJ, Mora-Gonzalez A, Pajaron-Fernandez MJ, Cabrejos-Perotti S, Meseguer-Arce J, Flores Martin I, Perez-Fernandez V; RE-ASGRAMUR Group. Effectiveness of Mepolizumab in Patients with Severe Eosinophilic Asthma with/without Nasal Polyposis: A Real-Life Study. Int Arch Allergy Immunol. 2024;185(3):253-259. doi: 10.1159/000534902. Epub 2023 Nov 30. PubMed PMID: 38035559.

AÑO: 2024; IF: 2.8

38035559